TLDR Cardiac risk markers help assess heart risk in males with type 2 diabetes and low DHT.
The study investigated the relationship between cardiac risk markers and serum DHT levels in males with type 2 diabetes, focusing on the under-researched androgen, DHT. Conducted in India, the study involved 210 participants, split evenly between type 2 diabetes patients and controls. Researchers analyzed lipid parameters and serum DHT using conventional biochemical methods. The study aimed to explore the association of androgens with cardiovascular risk indicators, particularly in the context of male hypogonadism, which is linked to dyslipidemia, visceral obesity, and cardiovascular disorders.
26 citations
,
April 2019 in “Journal of Cosmetic Dermatology” Herbal alternatives like saw palmetto and green tea may offer safe, effective treatment for hormonal hair loss.
10 citations
,
October 2006 in “Expert Opinion on Emerging Drugs” New treatments for male hypogonadism are easier to use and target specific tissues to reduce side effects.
4 citations
,
June 2017 in “Endocrine Reviews” Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.
January 2018 in “Elsevier eBooks” The document explains how male reproductive hormones work and affect the body.
January 2018 in “Journal of translational science” Eating alfalfa sprouts every day can raise testosterone levels in middle-aged men, but broccoli sprouts don't have this effect.
14 citations
,
December 1998 in “The Journal of Clinical Endocrinology and Metabolism” MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.
